Patents by Inventor Chia-Chen Wang

Chia-Chen Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11990545
    Abstract: A method for making a semiconductor device includes forming a ROX layer on a substrate and a patterned silicon oxynitride layer on the patterned ROX layer; conformally forming a dielectric oxide layer to cover the substrate, the patterned silicon oxynitride layer, and the patterned ROX layer; and fully oxidizing the patterned silicon oxynitride layer to form a fully oxidized gate oxide layer on the substrate.
    Type: Grant
    Filed: October 19, 2022
    Date of Patent: May 21, 2024
    Assignee: TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD.
    Inventors: Tsu-Hsiu Perng, Yun-Chi Wu, Chia-Chen Chang, Cheng-Bo Shu, Jyun-Guan Jhou, Pei-Lun Wang
  • Patent number: 11972799
    Abstract: A filament forming method includes: performing first stage to apply first bias including gate and drain voltages to a resistive memory unit plural times until read current reaches first saturating state, latching read current in first saturating state as saturating read current, determining whether rate of increase of saturating read current is less than first threshold value; when rate of increase of saturating read current is not less than first threshold value, performing second stage to apply second bias, by increasing gate voltage and decreasing drain voltage, to the resistive memory unit plural times until read current reaches second saturating state, latching read current in second saturating state as saturating read current and determining whether rate of increase of saturating read current is less than first threshold value; finishing the method when rate of increase of saturating read current is less than first threshold value and saturating read current reaches target current value.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: April 30, 2024
    Assignee: Winbond Electronics Corp.
    Inventors: Frederick Chen, Ping-Kun Wang, Chia-Hung Lin, Jun-Yao Huang
  • Patent number: 11962949
    Abstract: A method of performing air pollution estimation is provided. The method is to be implemented using a processor of a computer device and includes: generating a spectral image based on an original color image of an environment under test using a spectral transformation matrix; supplying the spectral image as an input into an estimating model for air pollution estimation; and obtaining an estimation result from the estimating model indicating a degree of air pollution of the environment under test.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: April 16, 2024
    Assignee: National Chung Cheng University
    Inventors: Hsiang-Chen Wang, Chia-Cheng Huang, Ting-Chun Men
  • Publication number: 20240098959
    Abstract: A method includes etching a first semiconductor fin and a second semiconductor fin to form first recesses. The first and the second semiconductor fins have a first distance. A third semiconductor fin and a fourth semiconductor fin are etched to form second recesses. The third and the fourth semiconductor fins have a second distance equal to or smaller than the first distance. An epitaxy is performed to simultaneously grow first epitaxy semiconductor regions from the first recesses and second epitaxy semiconductor regions from the second recesses. The first epitaxy semiconductor regions are merged with each other, and the second epitaxy semiconductor regions are separated from each other.
    Type: Application
    Filed: November 22, 2023
    Publication date: March 21, 2024
    Inventors: Kai-Hsuan Lee, Chia-Ta Yu, Cheng-Yu Yang, Sheng-Chen Wang, Sai-Hooi Yeong, Feng-Cheng Yang, Yen-Ming Chen
  • Publication number: 20240089062
    Abstract: A wireless communication method and apparatus for handling radio resource collision are provided. The wireless communication method includes receiving a Radio Resource Control (RRC) configuration indicating a first Control Resource Set (CORESET) pool index associated with a Physical Uplink Control Channel (PUCCH) designated to carry Uplink Control Information (UCI); determining whether the PUCCH overlaps one or more Physical Uplink Shared Channels (PUSCHs) in time domain; after determining that the PUCCH overlaps at least one of the one or more PUSCHs in the time domain, multiplexing the UCI on a particular PUSCH of the one or more PUSCHs that is associated with the first CORESET pool index; and transmitting the UCI via the particular PUSCH.
    Type: Application
    Filed: March 31, 2022
    Publication date: March 14, 2024
    Inventors: WAN-CHEN LIN, CHIA-HAO YU, CHIA-HUNG LIN, HAI-HAN WANG
  • Patent number: 11923433
    Abstract: A method for manufacturing a semiconductor device includes forming a first dielectric layer over a semiconductor fin. The method includes forming a second dielectric layer over the first dielectric layer. The method includes exposing a portion of the first dielectric layer. The method includes oxidizing a surface of the second dielectric layer while limiting oxidation on the exposed portion of the first dielectric layer.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: March 5, 2024
    Assignee: Taiwan Semiconductor Manufacturing Company, Ltd.
    Inventors: Sheng-Liang Pan, Yungtzu Chen, Chung-Chieh Lee, Yung-Chang Hsu, Chia-Yang Hung, Po-Chuan Wang, Guan-Xuan Chen, Huan-Just Lin
  • Publication number: 20230156958
    Abstract: A liquid cooling device includes a water cooling radiator, a first pump and a cold plate. The water cooling radiator has a first surface and a second surface, the first surface and the second surface are located on opposite sides of the water cooling radiator, the first pump is disposed on the first surface or the second surface of the water cooling radiator, and the cold plate is disposed on the second surface of the water cooling radiator.
    Type: Application
    Filed: October 26, 2022
    Publication date: May 18, 2023
    Inventors: Mu-Shu FAN, Chien-Chih SU, Hsing-Pao YU, Chia-Chen WANG
  • Patent number: 10047063
    Abstract: A method for improving the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes to organs or peripheral tissues in human bodies is disclosed by administering a compound of phthalides to a subject in need thereof. The compound of phthalides is characterized by a phthalide functional group which is represented as Formula I, and forms at least one hydrogen bond with ?Arg141 of hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes, stabilizing the ?1/?2 interface of hemoglobin, further stabilizing the oxygenated hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes in the low oxygen affinity “T” state and facilitating the oxygen release to the organs or the peripheral tissues.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: August 14, 2018
    Assignee: NATIONAL SUN YAT-SEN UNIVERSITY
    Inventors: Chia-Chen Wang, Muhammad Zulfajri, You-Qing Yu
  • Patent number: 9937150
    Abstract: The present invention relates to a method for substituting for or acting with the hyperbaric oxygen therapy to improve hypoxia, comprising the step of: administrating a phthalide compound to a subject in need thereof, wherein the phthalide compound can increase the oxygen release efficiency of blood hemoglobin (Hb) in the subject and further increase the cellular oxygenation level, and when the phthalide compound substitutes for or act with the hyperbaric oxygen therapy, the common adverse side effects of the hyperbaric oxygen therapy, such as barotrauma, decompression sickness and oxygen poisoning, are prevented. The phthalide compound is used to substitute for or act with 2,3-BPG, to modulate and decrease the oxygen affinity of hemoglobin (Hb), to increase the oxygen release efficiency of hemoglobin (Hb) to tissue cells, thereby achieving a normal cellular oxygenation level and maintaining the cellular oxygenation level in a normal range.
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: April 10, 2018
    Assignee: National Sun Yat-sen University
    Inventors: Chia-Chen Wang, Wei-Ren Chen
  • Publication number: 20170266155
    Abstract: The present invention relates to a method for substituting for or acting with the hyperbaric oxygen therapy to improve hypoxia, comprising the step of: administrating a phthalide compound to a subject in need thereof, wherein the phthalide compound can increase the oxygen release efficiency of blood hemoglobin (Hb) in the subject and further increase the cellular oxygenation level, and when the phthalide compound substitutes for or act with the hyperbaric oxygen therapy, the common adverse side effects of the hyperbaric oxygen therapy, such as barotrauma, decompression sickness and oxygen poisoning, are prevented. The phthalide compound is used to substitute for or act with 2,3-BPG, to modulate and decrease the oxygen affinity of hemoglobin (Hb), to increase the oxygen release efficiency of hemoglobin (Hb) to tissue cells, thereby achieving a normal cellular oxygenation level and maintaining the cellular oxygenation level in a normal range.
    Type: Application
    Filed: March 15, 2016
    Publication date: September 21, 2017
    Applicant: National Sun Yat-sen University
    Inventors: Chia-Chen Wang, Wei-Ren Chen
  • Publication number: 20170266154
    Abstract: The present invention relates to a method for treating Alzheimer's disease and 2,3-BPG metabolic disorder induced morbidities, comprising administrating a phthalide compound to an Alzheimer's disease patient or a patient having 2,3-BPG metabolic disorder induced morbidities, wherein the method is characterized by that the phthalide compound has the same effect as 2,3-BPG on modulating hemoglobin to reduce its oxygen affinity and can thus act as a 2,3-BPG functional substitute when the 2,3-BPG concentration is too low in the Alzheimer's disease patient or in the patient having 2,3-BPG metabolic disorder induced morbidities to maintain the normal oxygen release function of hemoglobin and therefore to maintain the normal cellular oxygenation level.
    Type: Application
    Filed: March 15, 2016
    Publication date: September 21, 2017
    Applicant: National Sun Yat-sen University
    Inventors: Chia-Chen Wang, Wei-Ren Chen
  • Publication number: 20170266156
    Abstract: The present invention relates to a method for preventing cancer by using a phthalide compound, wherein the phthalide compound has an effect of increasing the oxygen release efficiency of hemoglobin (Hb) of a subject to increase the oxygenation level of organs and tissue cells, thereby preventing the cellular oxygenation level against falling below the critical cellular oxygen requirements under which the normal cells can turn cancerous. Although cancer may be caused by a variety of reasons, including congenital inheritance, external environment, air pollution or poor living and dietary habits, there is only one primary and common reason in causing cancers, the excessively low cellular oxygenation level. When the oxygenation level of any cell falls below 60% of its physiological oxygen requirements, the normal cell may turn cancerous.
    Type: Application
    Filed: March 15, 2016
    Publication date: September 21, 2017
    Applicant: National Sun Yat-sen University
    Inventors: Chia-Chen Wang, Wei-Ren Chen
  • Patent number: 9713602
    Abstract: The present invention relates to a method for increasing the oxygen release efficiency of a hemoglobin-based blood substitute by using a phthalide compound, comprising the steps of: administering to a subject in need thereof the phthalide compound or co-administering to the subject in need thereof the phthalide compound along with the hemoglobin-based blood substitute, wherein the phthalide compound has an effect of increasing the oxygen release efficiency of the hemoglobin-based blood substitute, wherein the hemoglobin-based blood substitute can be fetal hemoglobin (HbF) or other Hb variants retaining two native ? subunits. The phthalide compound is used to substitute for or cooperate with 2,3-BPG, to play a role of a 2,3-BPG substitute, to act on the hemoglobin-based blood substitute to effectively substitute the function of normal hemoglobin in releasing oxygen to tissue cells, in order to maintain the cellular oxygenation level within a normal range.
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: July 25, 2017
    Assignee: NATIONAL SUN YAT-SEN UNIVERSITY
    Inventors: Chia-Chen Wang, Wei-Ren Chen
  • Publication number: 20170129866
    Abstract: A method for improving the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes to organs or peripheral tissues in human bodies is disclosed by administering a compound of phthalides to a subject in need thereof. The compound of phthalides is characterized by a phthalide functional group which is represented as Formula I, and forms at least one hydrogen bond with ?Arg141 of hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes, stabilizing the ?1/?2 interface of hemoglobin, further stabilizing the oxygenated hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes in the low oxygen affinity “T” state and facilitating the oxygen release to the organs or the peripheral tissues.
    Type: Application
    Filed: January 20, 2017
    Publication date: May 11, 2017
    Inventors: Chia-Chen Wang, Muhammad Zulfajri, You-Qing Yu
  • Publication number: 20170047215
    Abstract: An adjustable aerodynamic lens system for aerodynamic focusing of aerosols comprises a hollow tube having an inlet terminal, an outlet terminal and a focusing segment located between the inlet terminal and the outlet terminal. The focusing segment includes a plurality of section tubes assembled in a manner to selectively focus aerosols of a specific average size. Each of the section tubes has a focusing orifice, and the diameters of the two adjacent focusing orifices are different. In specific, the section tubes having their focusing orifices of appropriate diameters are chosen according to the average size of aerosol particles to be focused, and assembled in sequence, so as to make aerosol fluid passing through to form a beam of aerosol particles with good focusing quality.
    Type: Application
    Filed: February 5, 2016
    Publication date: February 16, 2017
    Inventor: Chia-Chen Wang
  • Publication number: 20160058732
    Abstract: A method for improving the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes to organs and peripheral tissues in human bodies is disclosed by administering a compound of phthalides to a subject in need thereof to improve the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes to the organs and the peripheral tissues in human bodies. The compound of phthalides is characterized by a phthalide functional group, and forms at least one hydrogen bond with ?Arg141 of hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes, stabilizing the ?1/?2 interface of hemoglobin, further stabilizing the oxygenated hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes in the low oxygen affinity “T” state and facilitating the oxygen release to the organs and the peripheral tissues.
    Type: Application
    Filed: June 12, 2015
    Publication date: March 3, 2016
    Inventors: Chia-Chen Wang, Muhammad Zulfajri, You-Qing Yu
  • Publication number: 20160058722
    Abstract: A method for improving the oxygen-releasing ability of hemoglobin to organs and peripheral tissues in human bodies is disclosed by administering ferulic acid to a subject in need thereof to improve the oxygen-releasing ability of hemoglobin to the organs and the peripheral tissues in human bodies. Ferulic acid forms a hydrogen bond with ?Val1 of hemoglobin, stabilizing the ?1/?2 interface of hemoglobin, further stabilizing the oxygenated hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes in the low oxygen affinity “T” state and facilitating the oxygen release to the organs and the peripheral tissues.
    Type: Application
    Filed: August 31, 2015
    Publication date: March 3, 2016
    Inventors: Chia-Chen WANG, Muhammad ZULFAJRI, You-Qing YU
  • Publication number: 20150077994
    Abstract: An improved structure of an LED light includes a light source module and a heat dissipation module. The light source module includes a plurality the compartments formed therein and each of the compartments receives therein a light reflector and a light emission element. The compartments are provided with a seat at an end thereof distant from the light emission elements. Each of the compartments is provided with a cover mounted thereon. The heat dissipation module has an outer wall forming a heat dissipation fin section. The heat dissipation module receives therein a drive module electrically connected to the light emission element. The heat dissipation module is coupled to the seat. With such an arrangement, the loss of light is minimized to achieve optimum utilization. The heat dissipation module is kept away from the light source module so that excellent effect of heat dissipation can be achieved.
    Type: Application
    Filed: September 16, 2013
    Publication date: March 19, 2015
    Applicant: TAI MING GREEN POWER CO., LTD.
    Inventors: CHIA-CHEN WANG, HUNG-KUANG YANG
  • Patent number: 8836659
    Abstract: An electronic apparatus with a touch input system is provided. When a complete touch signal is detected, a sliding angle and a sliding track of the complete touch signal are calculated. A menu operation interface with arc-shaped arrangement is displayed in a touch display screen when the sliding angle of the complete touch signal exceeds a predetermined angle. And when an incomplete touch signal is detected, a sliding angle and a sliding track of the incomplete touching signal are calculated for displaying a part of the menu operation interface with arc-shaped arrangement in the touch display screen.
    Type: Grant
    Filed: May 29, 2012
    Date of Patent: September 16, 2014
    Assignee: Compal Electronics, Inc.
    Inventors: Kai-Yi Chen, Yi-Chen Sung, Yu-Jen Huang, Chia-Chen Wang, Yen-Lin Lin, Hsiu-Hang Lin, Hui Lin, Chih-Yen Lan, Pei-Ching Hu, Yung-Yu Huang
  • Patent number: 8721364
    Abstract: An electrical connector, which is adapted to a printed circuit board (PCB) with a first connection port, comprises a bottom having a base and a conductive element mounted in an opening of the base, a second connection port disposing on the base, and a housing covering the bottom. When the bottom is disposed on the PCB, the first connection port is accommodated in the opening of the base, and an elastic strip of the conductive element presses on the first connection port toward a direction parallel to the PCB for combining the electrical connector and the first connection port on the PCB, and preventing the separation or loose connection of the electrical connector from the first connection port or the PCB.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: May 13, 2014
    Assignee: Giga-Byte Technology Co., Ltd.
    Inventors: Chih Ming Lai, Chia Chen Wang